JT
TBPH icon

Jupiter Topco’s Theravance Biopharma TBPH Stock Holding History

Jupiter Topco’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Buy
+387,493
New +$6.42M ﹤0.01% 939

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's TBPH Position: Q2 2026 in Review

Jupiter Topco opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 387,493 shares worth $6.59M. The stake represents ﹤0.01% of the portfolio and ranks #939 among its holdings.

166 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Jupiter Topco held 387,493 shares of Theravance Biopharma worth $6.59M as of Q2 2026.
  • Theravance Biopharma was a new Jupiter Topco position in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #939 holding.
  • 166 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.